HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C103. A total of 22 filers reported holding HEMISPHERX BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $209,000 | -15.0% | 1,811,100 | -2.2% | 0.00% | – |
Q1 2016 | $246,000 | +65.1% | 1,851,100 | +0.2% | 0.00% | – |
Q4 2015 | $149,000 | -37.4% | 1,847,734 | +32.2% | 0.00% | -100.0% |
Q3 2015 | $238,000 | +1.7% | 1,397,800 | +22.2% | 0.00% | 0.0% |
Q2 2015 | $234,000 | +52.9% | 1,143,900 | +70.1% | 0.00% | – |
Q1 2015 | $153,000 | +139.1% | 672,500 | +164.3% | 0.00% | – |
Q4 2014 | $64,000 | +166.7% | 254,400 | +245.2% | 0.00% | – |
Q3 2014 | $24,000 | -20.0% | 73,700 | -34.8% | 0.00% | – |
Q4 2013 | $30,000 | -65.1% | 113,000 | -69.2% | 0.00% | – |
Q3 2013 | $86,000 | +309.5% | 367,200 | +290.6% | 0.00% | – |
Q2 2013 | $21,000 | – | 94,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEDBUSH SECURITIES INC | 156,500 | $41,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 524,476 | $139,000 | 0.00% |
Investors Capital Advisory Services | 17,000 | $4,000 | 0.00% |
Joel Isaacson & Co., LLC | 15,500 | $4,000 | 0.00% |
CITY HOLDING CO | 5,000 | $1,000 | 0.00% |
UBS AG | 10,110 | $3,000 | 0.00% |
NOMURA HOLDINGS INC | 1,400 | $0 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 288,100 | $76,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 30,506 | $8,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 10,396 | $3,000 | 0.00% |